ENTITY
Precigen

Precigen (PGEN US)

3
Analysis
Health CareUnited States
Precigen, Inc. operates as a biopharmaceutical company. The Company develops gene and cell therapies to target the diseases in immuno-oncology, autoimmune disorders, and infections. Precigen serves customers worldwide.
more
Begin exploring Smartkarma's AI-augmented investing intelligence platform with a complimentary Preview Pass to:
  • Unlock research summaries
  • Follow top, independent analysts
  • Receive personalised alerts
  • Access Analytics, Events and more

Join 55,000+ investors, including top global asset managers overseeing $13+ trillion.

Upgrade later to our paid plans for full-access.

or
Already have an account? Sign In Now
x